This week, Peter Simons covers a study that found prescribing rates for ADHD drugs did not increase after positive evidence from the MTA study was published, nor decrease when negative evidence from the same study's long-term arm was published. He also covers a study that found physician disclosure of financial conflicts of interest has not changed behavior to reduce industry bias.

• Stimulant Prescribing Patterns for ADHD Not Impacted by Scientific Evidence
• Transparency is Not Enough to Stem Tide of Pharma Influence on Medicine

Visit madinamerica.com for more news, articles and research updates.